(Q46689599)
Statements
1 reference
Fludarabine in combination with alemtuzumab is effective and feasible in patients with relapsed or refractory B-cell chronic lymphocytic leukemia: results of a phase II trial (English)
1 reference
Michael Hallek
1 reference
Thomas Elter
1 reference
Peter Borchmann
1 reference
Holger Schulz
1 reference
Marcel Reiser
1 reference
Sven Trelle
1 reference
Roland Schnell
1 reference
Markus Jensen
1 reference
Peter Staib
1 reference
Timo Schinköthe
1 reference
Hartmut Stützer
1 reference
Jürgen Rech
1 reference
Martin Gramatzki
1 reference
Walter Aulitzky
1 reference
Ibrahim Hasan
1 reference
Andreas Josting
1 reference
Andreas Engert
1 reference
6 September 2005
1 reference
23
1 reference
28
1 reference
7024-7031
1 reference